Additionally, enforcing PD-L1 expression on β cells under the insulin promoter has shown conflicting results, as NOD mice were protected from disease28 while diabetes-resistant mice were rendered susceptible with insulin promoter-driven PD-L1 expression29. The gene discussed is INS; the disease is diabetes mellitus.